CN102988509B - Preparation method and application of bone-knitting tablet - Google Patents
Preparation method and application of bone-knitting tablet Download PDFInfo
- Publication number
- CN102988509B CN102988509B CN 201210388907 CN201210388907A CN102988509B CN 102988509 B CN102988509 B CN 102988509B CN 201210388907 CN201210388907 CN 201210388907 CN 201210388907 A CN201210388907 A CN 201210388907A CN 102988509 B CN102988509 B CN 102988509B
- Authority
- CN
- China
- Prior art keywords
- tablet
- preparation
- extraction
- processed
- curing fracture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a preparation method of a bone-knitting tablet. The bone-knitting tablet is prepared by using 39g of szechuan lovage rhizome, 39g of radix aconiti preparata, 39g of Chinese angelica, 39g of frankincense stir-fried with vinegar, 39g of myrrh stir-fried with vinegar and 39g of forged natural coppers as bulk drugs and adopting supercritical extraction and microwave-assisted extraction modes. By adopting the method, the content of ferulic acid is greatly improved; and the invention also provides application of the bone-knitting tablet in preparation of drugs for inhibiting cell proliferation of mice leukemia cell NFS-60.
Description
Technical field
The present invention relates to the Chinese medicine preparation technical field, be specifically related to a kind of preparation method and application of tablet for curing fracture.
Background technology
Tablet for curing fracture is recorded in Ministry of Public Health standard WS3-B-0402-90, by Rhizoma Chuanxiong 39g, Radix Aconiti Preparata 39g, Radix Angelicae Sinensis 39g, processed with vinegar Olibanum 39g, processed with vinegar Myrrha 39g, Pyritum (calcined) 39g, as crude drug, made, can dissipating blood stasis, invigorate blood circulation, pain relieving, for traumatic injury, injury of tendon and muscle fracture, swelling and pain due to blood stasis.
In prior art, not yet there is tablet for curing fracture to adopt the report of supercritical and microwave technology extracting aspect preparation, and adopt the method that powder and decocting boil of beating, technique is coarse, backward, and impurity is many, causes patient's consumption excessive, be inconvenient to take, had a strong impact on this product and applied clinically.
Summary of the invention
Goal of the invention: in order to address the above problem, the object of the present invention is to provide a kind of preparation method of tablet for curing fracture.
Another object of the present invention is to provide a kind of tablet for curing fracture to suppress the application in mouse leukemia cell NFS-60 cell proliferation medicine in preparation.
Technical scheme: the objective of the invention is to realize by following scheme:
A kind of preparation method of tablet for curing fracture, by Rhizoma Chuanxiong 39g, Radix Aconiti Preparata 39g, Radix Angelicae Sinensis 39g, processed with vinegar Olibanum 39g, processed with vinegar Myrrha 39g, Pyritum (calcined) 39g, as crude drug, made, described method is comprised of the following step: get Rhizoma Chuanxiong, Radix Angelicae Sinensis, processed with vinegar Olibanum, processed with vinegar Myrrha, join in CO2 supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 4-6%, extracting pressure 15-30MPa, temperature 30-50 ℃, CO
2flow 1-3m1/g crude drug min, extraction time 150-180min, obtain supercritical extract, standby; Get all the other Chinese medicines, pulverize, add 70% ethanol of 2L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 400-600W, extract 2 times, each 4-8 minute, combining extraction liquid, concentrated, be added on the D102 macroporous adsorptive resins, 50% ethanol elution, collect 5 times of amount column volume eluents, decompression recycling ethanol, concentrated and dry, obtain the microwave extraction thing, standby; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, drying, tabletting, make 1000, every heavy 0.5g.
The preparation method of above-mentioned a kind of tablet for curing fracture, described CO
2the percent by volume that the supercritical extraction entrainer accounts for total extractant is 5%.
The preparation method of above-mentioned a kind of tablet for curing fracture, described microwave extracting power 500W extracts 6 minutes at every turn.
The preparation method of above-mentioned a kind of tablet for curing fracture, described CO
2the extracting pressure 20MPa of supercritical extraction, 40 ℃ of temperature, CO
2flow 2ml/g crude drug min, extraction time 160min.
Above-mentioned tablet for curing fracture suppresses the application in mouse leukemia cell NFS-60 cell proliferation medicine in preparation.
In prior art, every 0.5g of tablet for curing fracture, each 2,2 times on the one, the every 0.5g of tablet for curing fracture that adopts the present invention to be prepared into only needs 1 at every turn, within 1st, takes 2 times, has greatly reduced dose having under the condition of more active component.This conclusion can be by following evidence.
The comparison of ferulaic acid content in tablet for curing fracture prepared by test one, distinct methods
1, instrument and reagent tablet for curing fracture of the present invention: press embodiment 3 method preparations, use the 195g crude drug, through extraction, make 1000, every heavy 0.5g.Former tablet for curing fracture, by the preparation of ministry standard method, used the 195g crude drug, through extraction, makes 1000, every heavy 0.5g.Agilent 1200 high performance liquid chromatographs; METTLER AE240 electronic analytical balance; Ferulic acid reference substance (Nat'l Pharmaceutical & Biological Products Control Institute).
2, method
Chromatographic condition and system suitability: with octadecylsilane chemically bonded silica, be filler; Methanol-water-phosphoric acid (40:60:0.2) is mobile phase; The detection wavelength is 280nm.Number of theoretical plate is pressed the ferulic acid peak and is calculated, and should be not less than 3000.
The preparation of reference substance solution: precision takes at 60 ℃ of drying under reduced pressure ferulic acid reference substance of 4 hours appropriate, adds methanol and makes the solution of every 1ml containing 18 μ g, obtains.
The preparation of need testing solution: get tablet for curing fracture of the present invention and former tablet for curing fracture, porphyrize, mix, and gets 1g, accurately weighed, and precision adds 70% ethanol 20ml, close plug, and supersound process 10 minutes, centrifugal, get supernatant, obtain.
Algoscopy is accurate reference substance solution and each 20 μ l of need testing solution of drawing respectively, and the injection liquid chromatography, measure, and obtains.
3, result
Result shows, in tablet for curing fracture of the present invention, the content of ferulic acid is the 2.34mg/ sheet; And in former tablet for curing fracture, the content of ferulic acid is the 0.65mg/ sheet, in the situation that dose reduces, ferulaic acid content improves a lot.
Above-mentioned research shows, the tablet for curing fracture that adopts the present invention to prepare, the tablet for curing fracture that active constituent content is standby higher than the ministry standard legal system.
The specific embodiment
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as to the scope of the above-mentioned theme of the present invention only limits to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
Embodiment 1
Get Rhizoma Chuanxiong 39g, Radix Aconiti Preparata 39g, Radix Angelicae Sinensis 39g, processed with vinegar Olibanum 39g, processed with vinegar Myrrha 39g, Pyritum (calcined) 39g, by Rhizoma Chuanxiong, Radix Angelicae Sinensis, processed with vinegar Olibanum, processed with vinegar Myrrha, join in CO2 supercritical extraction device, ethanol is as entrainer, the percent by volume that entrainer accounts for total extractant is 4%, extracting pressure 15MPa, 30 ℃ of temperature, CO
2flow 1m1/g crude drug min, extraction time 150min, obtain supercritical extract, standby; Get all the other Chinese medicines, pulverize, add 70% ethanol of 2L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 400W, extract 2 times, each 4 minutes, combining extraction liquid, concentrated, be added on the D102 macroporous adsorptive resins, 50% ethanol elution, collect 5 times of amount column volume eluents, decompression recycling ethanol, concentrated and dry, obtain the microwave extraction thing, standby; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, drying, tabletting, make 1000, every heavy 0.5g.
After testing, in finished product, the content of ferulic acid is the 2.55mg/ sheet.
Embodiment 2
Get Rhizoma Chuanxiong 39g, Radix Aconiti Preparata 39g, Radix Angelicae Sinensis 39g, processed with vinegar Olibanum 39g, processed with vinegar Myrrha 39g, Pyritum (calcined) 39g, by Rhizoma Chuanxiong, Radix Angelicae Sinensis, processed with vinegar Olibanum, processed with vinegar Myrrha, join CO
2in the supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 6%, extracting pressure 30MPa, temperature 50 C, CO
2flow 3m1/g crude drug min, extraction time 180min, obtain supercritical extract, standby; Get all the other Chinese medicines, pulverize, add 70% ethanol of 2L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 600W, extract 2 times, each 8 minutes, combining extraction liquid, concentrated, be added on the D102 macroporous adsorptive resins, 50% ethanol elution, collect 5 times of amount column volume eluents, decompression recycling ethanol, concentrated and dry, obtain the microwave extraction thing, standby; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, drying, tabletting, make 1000, every heavy 0.5g.
After testing, in finished product, the content of ferulic acid is the 2.54mg/ sheet.
Embodiment 3
Get Rhizoma Chuanxiong 39g, Radix Aconiti Preparata 39g, Radix Angelicae Sinensis 39g, processed with vinegar Olibanum 39g, processed with vinegar Myrrha 39g, Pyritum (calcined) 39g, by Rhizoma Chuanxiong, Radix Angelicae Sinensis, processed with vinegar Olibanum, processed with vinegar Myrrha, join CO
2in the supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 5%, extracting pressure 20MPa, 40 ℃ of temperature, CO
2flow 2m1/g crude drug min, extraction time 160min, obtain supercritical extract, standby; Get all the other Chinese medicines, pulverize, add 70% ethanol of 2L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 500W, extract 2 times, each 6 minutes, combining extraction liquid, concentrated, be added on the D102 macroporous adsorptive resins, 50% ethanol elution, collect 5 times of amount column volume eluents, decompression recycling ethanol, concentrated and dry, obtain the microwave extraction thing, standby; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, drying, tabletting, make 1000, every heavy 0.5g.
After testing, in finished product, the content of ferulic acid is the 2.34mg/ sheet.
Embodiment 4: tablet for curing fracture suppresses the experimentation data of NFS-60 cell proliferation
1 experiment material
1.1 experiment cell strain
Mouse leukemia cell (NFS-60), Nanjing Zhengkuan Pharmaceutical Technology Co., Ltd.'s laboratory cell bank, DMEM+10%FBS cellar culture.
1.2 Experimental agents
Drugs: tablet for curing fracture of the present invention: press embodiment 3 method preparations.
The medicinal liquid liquid storage: take the 100mg tablet for curing fracture, be dissolved in the 5ml dehydrated alcohol, 0.2 μ m filter filters, 500 μ l doff pipe packing, and-20 ℃ of storages, 0.2 μ m filter filters the use of dehydrated alcohol in order to matched group simultaneously.
1.3 experiment reagent
The Cat.No.12100-061 Lot.No.758137 of DMEM(GIBCO company); Hyclone (Hangzhoupro, sky, Zhejiang bio tech ltd Lot.No.100419); NaHCO3(Shanghai hundred million chemical reagent company limited Cat.No.11810-033 Lot.No.1088387 of a specified duration); Trypsin(AMRESCO company lot number: 2010/04); EDTA(AMRESCO company lot number: 2009/10); Penicillin G Sodium Salt(AMRESCO company lot number: 2010242); Streptomycin Sulfate(AMRESCO company lot number: 2010382); Dehydrated alcohol (Nanjing Chemistry Reagent Co., Ltd.'s lot number: 080310182); MTT (Biosharp lot number: 0793); The autogamy of PBS(laboratory);
1.4 experiment equipment
Lycra inverted microscope (German Leica model: DM1L); Visible-ultraviolet light microwell plate detector (U.S. MD company model: SPECTRAMAX 190); CO2 incubator (FORMA model: 3111); (safe and sound company of Su Jing group manufactures model to super-clean bench: SW-CJ-ZFD); Pure water instrument (U.S. Spring company model: S/N 020579); Accurate pipettor (French Gilson Inc model: P2); Electronic balance (German Sai Duolisi company limited model: BT323S); Full-automatic high-pressure autoclave (Japanese SANYO company model: MLS-3020); Table electrothermal air dry oven (Shanghai accurate experimental facilities company model: DHG9123A); Refrigerator (Siemens Company's model: KG18V21TI); Liquid nitrogen container (CBS model: 2001); Low speed centrifuge (Anting Scientific Instrument Factory, Shanghai's model: KA-1000); 0.2 μ m filter (MILLIPORE model: SLGP033RB); 10cm culture dish (NEST company), 96 well culture plates (NEST company); Cell counting count board; Centrifuge tube, pipet, Tips are some.
2 experimental techniques
1) the NFS-60 cell carries out cellar culture (10cm culture dish) with DMEM+10%FBS in 37 ℃, 5%CO2, when Growth of Cells during to logarithmic (log) phase, collecting cell, discard culture fluid, PBS fine laundering 3 times, add 3ml 0.25% trypsin-0.04%EDTA, after 37 ℃ of digestion 2min, add wherein 5ml complete medium neutralization reaction, after the piping and druming cell, it is proceeded in centrifuge tube, the centrifugal 5min of 1000rpm, adjust 3 * 104/ml of concentration of cell suspension.
2) the cell kind is entered in 96 well culture plates, every hole adds cell suspension 180 μ l, culture plate put into cell culture incubator (37 ℃, 5%CO2) cellar culture.
3) according to the Growth of Cells situation, generally grow to 50%-70%, add tablet for curing fracture solution, continue to cultivate 24h.
4) add 20 μ l MTT solution (5mg/ml, i.e. 0.5%MTT) after 24h, continue to cultivate 4h.
5) after 4h, the buckle method is removed supernatant, with absorbent paper, pats dry gently, and every hole adds 200 μ l dimethyl sulfoxide, puts low-speed oscillation 10min on shaking table, and crystal is fully dissolved.Measure the light absorption value in each hole at enzyme-linked immunosorbent assay instrument 490nm place.
6) background (do not add cell, only add culture fluid) is set simultaneously, control wells (the medicine dissolution medium of cell, same concentrations, culture fluid, MTT, dimethyl sulfoxide), set 6 multiple holes for every group.
7) with medicine, the suppression ratio to cell means result:
Cell increment suppression ratio (%)=(control wells OD value-dosing holes OD value)/control wells OD value * 100%.Experiment repeats 3 times.
3 statistical dispositions
Adopt correlation analysis and Student t check in Microsoft Excel 2003 softwares, data mean with mean ± S.D..
4 experimental results
Statistical result showed after the mtt assay experiment, with matched group, compare, when dosage reaches 5mg/ml, to NFS-60 cell inhibitory effect variant (P<0.05), dosage this difference when 10mg/ml has significance (P<0.01), and utmost point significant difference (P<0.001) is arranged when dosage reaches 15-20mg/ml.
Table 1 tablet for curing fracture is on NFS-60 cell inhibitory effect impact research
Annotate: compare * P<0.01 with matched group; * P<0.001
5 experiment conclusion
Tablet for curing fracture can suppress the NFS-60 cell proliferation, reduces the Growth of Cells number of NFS-60 cell, and this effect is dose dependent.
Claims (4)
1. a tablet for curing fracture suppresses the application in mouse leukemia cell NFS-60 cell proliferation medicine in preparation, it is characterized in that tablet for curing fracture made as crude drug by Rhizoma Chuanxiong 39g, Radix Aconiti Preparata 39g, Radix Angelicae Sinensis 39g, processed with vinegar Olibanum 39g, processed with vinegar Myrrha 39g, Pyritum (calcined) 39g, preparation method is comprised of the following step: get Rhizoma Chuanxiong, Radix Angelicae Sinensis, processed with vinegar Olibanum, processed with vinegar Myrrha, join CO
2in the supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 4-6%, extracting pressure 15-30MPa, temperature 30-50 ℃, CO
2flow 1-3ml/g crude drug min, extraction time 150-180min, obtain supercritical extract, standby; Get all the other Chinese medicines, pulverize, add 70% ethanol of 2L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 400-600W, extract 2 times, each 4-8 minute, combining extraction liquid, concentrated, be added on the D102 macroporous adsorptive resins, 50% ethanol elution, collect 5 times of amount column volume eluents, decompression recycling ethanol, concentrated and dry, obtain the microwave extraction thing, standby; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, drying, tabletting, make 1000, every heavy 0.5g.
2. tablet for curing fracture suppresses the application in mouse leukemia cell NFS-60 cell proliferation medicine in preparation according to claim 1, it is characterized in that CO described in the preparation method of tablet for curing fracture
2the percent by volume that the supercritical extraction entrainer accounts for total extractant is 5%.
3. tablet for curing fracture suppresses the application in mouse leukemia cell NFS-60 cell proliferation medicine in preparation according to claim 1, it is characterized in that microwave extracting power 500W described in the preparation method of tablet for curing fracture, extracts 6 minutes at every turn.
4. tablet for curing fracture suppresses the application in mouse leukemia cell NFS-60 cell proliferation medicine in preparation according to claim 1, it is characterized in that CO described in the preparation method of tablet for curing fracture
2the extracting pressure 20MPa of supercritical extraction, 40 ℃ of temperature, CO
2flow 2ml/g crude drug min, extraction time 160min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210388907 CN102988509B (en) | 2012-10-15 | 2012-10-15 | Preparation method and application of bone-knitting tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210388907 CN102988509B (en) | 2012-10-15 | 2012-10-15 | Preparation method and application of bone-knitting tablet |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102988509A CN102988509A (en) | 2013-03-27 |
| CN102988509B true CN102988509B (en) | 2013-12-25 |
Family
ID=47917935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210388907 Expired - Fee Related CN102988509B (en) | 2012-10-15 | 2012-10-15 | Preparation method and application of bone-knitting tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102988509B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105106151B (en) * | 2015-09-16 | 2018-03-23 | 韩志强 | A kind of tablet for curing fracture and preparation method thereof |
| CN107375596A (en) * | 2017-09-26 | 2017-11-24 | 南京晶云化工有限公司 | A kind of medical plaster and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102359992B (en) * | 2011-08-26 | 2012-12-19 | 通化正和药业有限公司 | Bone-setting tablet, method thereof for identifying and measuring content |
| CN102397451B (en) * | 2011-11-26 | 2013-06-19 | 苏州派腾生物医药科技有限公司 | Preparation method of cholagogic tablet |
-
2012
- 2012-10-15 CN CN 201210388907 patent/CN102988509B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102988509A (en) | 2013-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102988526B (en) | Method for preparing Bailing tablets and application | |
| CN102988667B (en) | Preparation method and application of tablet for regulating menstruation and activating blood | |
| CN102988577B (en) | Preparation method and application of brain-soothing hypertension pill | |
| CN102988665B (en) | Method for preparing gynecological menstruation regulating tablets and application | |
| CN102988612B (en) | Preparation method and application of tablet for clearing away heat | |
| CN102988502B (en) | Preparation method and application of Desheng tablet | |
| CN103028005B (en) | Preparation method of anti-lumbago tablet and application thereof | |
| CN102988545B (en) | Preparation method and application of Yulian tablet | |
| CN102988480A (en) | Method for preparing bile and patchouli rhinitis tablets and application | |
| CN102988489B (en) | Preparation method and application of nose comforting tablet | |
| CN102988479B (en) | Preparation method and application of anti-dazzling tablet | |
| CN102988509B (en) | Preparation method and application of bone-knitting tablet | |
| CN102988550B (en) | Preparation method and application of qinlian tablet | |
| CN102836381B (en) | A kind of preparation method of regulating the spleen and stomach sheet and application | |
| CN102988614B (en) | Preparation method and application of antiphlogosis tablet | |
| CN102988881B (en) | Preparation method and application of pulse unblocking tablet | |
| CN102988501B (en) | Preparation method and application of Libiling tablet | |
| CN102988500B (en) | Method for preparing compound Dantong tablets and application | |
| CN102973749A (en) | Preparation method and applications of divaricate saposhnikovia-angelica archang lica rhinitis tablets | |
| CN102988611B (en) | Preparation method and application of antihypertension tablet | |
| CN102988522B (en) | Preparation method and application of naodesheng tablets | |
| CN102988691B (en) | Preparation method and application of liver-strengthening tablet | |
| CN102988749B (en) | Preparation method and application of body-building tablet | |
| CN102988576B (en) | Preparation method and application of nine-ingredient notopterygium root tablets | |
| CN102988836B (en) | Preparation method and application of Fuganning tablets |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHANG PENG Free format text: FORMER OWNER: LI ZHENGMEI Effective date: 20131122 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Peng Inventor before: The inventor has waived the right to be mentioned |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 211200 NANJING, JIANGSU PROVINCE TO: 250000 JINAN, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: ZHANG PENG |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20131122 Address after: 250000 Ji'nan Province, Lixia District, Shandong Cultural West Road, No. 44, building 207, No. 3 Applicant after: Zhang Peng Address before: 211200, No. 1, Shandong Road, Lishui Economic Development Zone, Nanjing, Jiangsu Applicant before: Li Zhengmei |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131225 Termination date: 20151015 |
|
| EXPY | Termination of patent right or utility model |